Rankings
Pricing
Log In
Free Trial
US-listed companies
Acasti Pharma Inc.
Acasti Pharma Inc.
ACST
Market cap
$25.57M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
CAD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Net Income (Loss)
-26
-20
-10
-42
Depreciation
0
0
-
0
Impairment of intangible assets
-
4
-
29
Impairment of goodwill
-
-
-
-5
Impairment of assets held for sale
-
-
-
-0
Stock-based compensation expense
-
1
1
2
Fair Value Adjustment of Warrants
1
2
-5
-0
Income tax recovery
-
-
-1
-10
Unrealized foreign exchange loss
-
-1
0
-0
Write Off Of Equipment
-
-
-
0
Changes in operating assets and liabilities
-
-
-
-0
Net cash used in operating activities
-
-14
-17
-16
Acquisition of equipment
-
0
-
0
Acquisition of short-term investments
-
10
35
5
Maturity of short-term investments
-
0
31
18
Net cash used in investing activities
-
-10
-4
13
Proceeds from Issuance of Common Stock
-
59
-
0
Net cash from financing activities
-
59
-
0
Effect of exchange rate fluctuations on cash and cash equivalents
-
6
0
-0
Translation effect on cash and cash equivalents related to reporting currency
-
-5
0
-
Net decrease in cash and cash equivalents
-
37
-21
-2